Kurumsal basın bülteni
30 Apr 2021

“On behalf of the Executive Board and the employees of GEA, I would like to thank the departing Supervisory Board members for their many years of service and great dedication to the Group. They are part of the reason why GEA is currently so well positioned despite the challenging economic environment,” said Stefan Klebert, CEO of GEA Group AG. “At the same time, I am pleased to welcome our new members, who join the Supervisory Board with a wealth of expertise, and I look forward to our successful cooperation.”
At today’s AGM, the shareholder representatives on the Supervisory Board were newly elected for a four-year term. Professor Annette G. Köhler, Dr. Molly P. Zhang and Colin Hall were re-elected. In addition, Holly Lei, Klaus Helmrich and Professor Jürgen Fleischer were appointed as new Supervisory Board members. These new members replace Dr. Helmut Perlet, Jean E. Spence and Ahmad M.A. Bastaki, who served on GEA’s Supervisory Board for many years and did not stand for re-election.
By resolution of the Düsseldorf Local Court, the serving Supervisory Board members Brigitte Krönchen and Michael Kämpfert as well as two new members, Claudia Claas and Roger Falk, were appointed as employee representatives on the Supervisory Board. Dr. Cara Röhner and existing member Rainer Gröbel – who represent German trade union IG Metall – were also appointed by the court.
Klaus Helmrich, GEA Group AG’s newly elected Supervisory Board Chairman, said: “I look forward to helping steer GEA’s continued success as part of the newly constituted Supervisory Board and to build on the excellent work done by the outgoing members.”
The personnel changes also affect the Presiding Committee and other Supervisory Board committees. Details of the new composition of these committees can be found online at gea.com.
Media Relations
GEA Group Aktiengesellschaft
Ulmenstrasse 99
40476
Düsseldorf
Germany
+49 211 9136-0
GEA is one of the world’s largest suppliers of systems and components to the food, beverage and pharmaceutical industries.
The international technology group, founded in 1881, focuses on machinery and plants, as well as advanced process technology, components and comprehensive services. For instance, every second pharma separator for essential healthcare products such as vaccines or novel biopharmaceuticals is produced by GEA. In food, every fourth package of pasta or every third chicken nugget are processed with GEA technology.
With more than 18,000 employees, the group generated sales of about EUR 5.5 billion in more than 150 countries in the 2025 fiscal year. GEA plants, processes, components and services enhance the efficiency and sustainability of customers’ production. They contribute significantly to the reduction of CO2 emissions, plastic usage and food waste. In doing so, GEA makes a key contribution toward a sustainable future, in line with the company’s purpose: ”Engineering for a better world.”
GEA is listed on the German MDAX, the European STOXX® Europe 600 Index and is also a constituent of the leading sustainability indices DAX 50 ESG, MSCI Global Sustainability and Dow Jones Best-in-Class World.